Cargando…

Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes

OBJECTIVE: Exenatide treatment improves glycemia in adults with type 2 diabetes and has been shown to reduce postprandial hyperglycemia in adolescents with type 1 diabetes. We studied the effects of exenatide on glucose homeostasis in adults with long-standing type 1 diabetes. RESEARCH DESIGN AND ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarkar, Gayatri, Alattar, May, Brown, Rebecca J., Quon, Michael J., Harlan, David M., Rother, Kristina I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2014
Materias:	Clinical Care/Education/Nutrition/Psychosocial Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931382/ https://www.ncbi.nlm.nih.gov/pubmed/24194508 http://dx.doi.org/10.2337/dc13-1473

Ejemplares similares

Response to Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670
por: Sarkar, Gayatri, et al.
Publicado: (2014)

Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study
por: Abdul-Ghani, Muhammad, et al.
Publicado: (2017)

Effect of Exenatide, Sitagliptin, or Glimepiride on β-Cell Secretory Capacity in Early Type 2 Diabetes
por: Gudipaty, Lalitha, et al.
Publicado: (2014)

Effects of Dietary n-3 Fatty Acids on Hepatic and Peripheral Insulin Sensitivity in Insulin-Resistant Humans
por: Lalia, Antigoni Z., et al.
Publicado: (2015)

Effect of a Successful Intensive Lifestyle Program on Insulin Sensitivity and Glucose Tolerance in Obese Youth
por: Shaw, Melissa, et al.
Publicado: (2009)

Long-Term Follow-Up of Oral Glucose Tolerance Test–Derived Glucose Tolerance and Insulin Secretion and Insulin Sensitivity Indexes in Subjects With Glucokinase Mutations (MODY2)
por: Martin, Delphine, et al.
Publicado: (2008)

Effect of Supervised Progressive Resistance-Exercise Training Protocol on Insulin Sensitivity, Glycemia, Lipids, and Body Composition in Asian Indians With Type 2 Diabetes
por: Misra, Anoop, et al.
Publicado: (2008)

Insulin Dose and Cardiovascular Mortality in the ACCORD Trial
por: Siraj, Elias S., et al.
Publicado: (2015)

Is a Priming Dose of Insulin Necessary in a Low-Dose Insulin Protocol for the Treatment of Diabetic Ketoacidosis?
por: Kitabchi, Abbas E., et al.
Publicado: (2008)

Determining starting basal rates of insulin infusion for insulin pump users: a comparison between methods
por: Chow, Nelson, et al.
Publicado: (2016)

A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (ONSET 9)
por: Lane, Wendy S., et al.
Publicado: (2020)

Influence of and Optimal Insulin Therapy for a Low–Glycemic Index Meal in Children With Type 1 Diabetes Receiving Intensive Insulin Therapy
por: Ryan, Rochelle L., et al.
Publicado: (2008)

Extended insulin boluses cannot control postprandial glycemia as well as a standard bolus in children and adults using insulin pump therapy
por: Lopez, Prudence, et al.
Publicado: (2014)

Neuronal T-Cell Autoreactivity Is Amplified in Overweight Children With New-Onset Insulin-Requiring Diabetes
por: Buryk, Melissa A., et al.
Publicado: (2015)

Comparison of Glycemic Variability Associated With Insulin Glargine and Intermediate-Acting Insulin When Used as the Basal Component of Multiple Daily Injections for Adolescents With Type 1 Diabetes
por: White, Neil H., et al.
Publicado: (2009)

Effect of Age of Infusion Site and Type of Rapid-Acting Analog on Pharmacodynamic Parameters of Insulin Boluses in Youth With Type 1 Diabetes Receiving Insulin Pump Therapy
por: Swan, Karena L., et al.
Publicado: (2009)

Beneficial Effects of Insulin on Glycemic Control and β-Cell Function in Newly Diagnosed Type 2 Diabetes With Severe Hyperglycemia After Short-Term Intensive Insulin Therapy
por: Chen, Harn-Shen, et al.
Publicado: (2008)

Effect of Vitamin K Supplementation on Insulin Resistance in Older Men and Women
por: Yoshida, Makiko, et al.
Publicado: (2008)

Randomized Controlled Trial of Insulin Supplementation for Correction of Bedtime Hyperglycemia in Hospitalized Patients With Type 2 Diabetes
por: Vellanki, Priyathama, et al.
Publicado: (2015)

Maternal Physical Activity and Insulin Action in Pregnancy and Their Relationships With Infant Body Composition
por: Pomeroy, Jeremy, et al.
Publicado: (2013)

Determinants of weight change in patients on basal insulin treatment: an analysis of the DIVE registry
por: Bramlage, Peter, et al.
Publicado: (2017)

What End Users and Stakeholders Want From Automated Insulin Delivery Systems
por: Naranjo, Diana, et al.
Publicado: (2017)

Androstenedione and testosterone levels correlate with in vitro fertilization rates in insulin-resistant women
por: Sathyapalan, Thozhukat, et al.
Publicado: (2017)

Psychological barriers to optimal insulin therapy: more concerns in adolescent females than males
por: Wisting, Line, et al.
Publicado: (2016)

Insulin therapy and dietary adjustments to normalize glycemia and prevent nocturnal hypoglycemia after evening exercise in type 1 diabetes: a randomized controlled trial
por: Campbell, Matthew D, et al.
Publicado: (2015)

Comparison of Once- Versus Twice-Daily Administration of Insulin Detemir, Used With Mealtime Insulin Aspart, in Basal-Bolus Therapy for Type 1 Diabetes: Assessment of Detemir Administration in a Progressive Treat-To-Target Trial (ADAPT)
por: Le Floch, Jean-Pierre, et al.
Publicado: (2009)

Optimizing Postprandial Glycemia in Pediatric Patients With Type 1 Diabetes Using Insulin Pump Therapy: Impact of glycemic index and prandial bolus type
por: O'Connell, Michele A., et al.
Publicado: (2008)

Momentary Predictors of Insulin Restriction Among Adults With Type 1 Diabetes and Eating Disorder Symptomatology
por: Merwin, Rhonda M., et al.
Publicado: (2015)

Plasma glucose and insulin response to two oral nutrition supplements in adults with type 2 diabetes mellitus
por: Huhmann, Maureen B, et al.
Publicado: (2016)

A randomized controlled trial comparing treatment with oral agents and basal insulin in elderly patients with type 2 diabetes in long-term care facilities
por: Pasquel, Francisco J, et al.
Publicado: (2015)

Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA(1c), and Insulin Dose
por: Hao, Wei, et al.
Publicado: (2016)

Glucose Regulation Beyond HbA(1c) in Type 2 Diabetes Treated With Insulin: Real-World Evidence From the DIALECT-2 Cohort
por: den Braber, Niala, et al.
Publicado: (2021)

Two-Year Pulmonary Safety and Efficacy of Inhaled Human Insulin (Exubera) in Adult Patients With Type 2 Diabetes
por: Rosenstock, Julio, et al.
Publicado: (2008)

Bubble formation occurs in insulin pumps in response to changes in ambient temperature and atmospheric pressure but not as a result of vibration
por: Lopez, Prudence E, et al.
Publicado: (2014)

Multisystemic Therapy for Adolescents With Poorly Controlled Type 1 Diabetes: Reduced diabetic ketoacidosis admissions and related costs over 24 months
por: Ellis, Deborah, et al.
Publicado: (2008)

Adjust to Target in Type 2 Diabetes: Comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine
por: Bergenstal, Richard M., et al.
Publicado: (2008)

Dipeptidyl Peptidase-4 Inhibition by Vildagliptin and the Effect on Insulin Secretion and Action in Response to Meal Ingestion in Type 2 Diabetes
por: Dalla Man, Chiara, et al.
Publicado: (2009)

Regional Primary Care Team to Deliver Best-Practice Diabetes Care: A needs-driven health workforce model reflecting a biopsychosocial construct of health
por: Segal, Leonie, et al.
Publicado: (2013)

Urinary C peptide creatinine ratio in pregnant women with normal glucose tolerance and type 1 diabetes: evidence for insulin secretion
por: Markoska, Ankica, et al.
Publicado: (2017)

BeAM value: an indicator of the need to initiate and intensify prandial therapy in patients with type 2 diabetes mellitus receiving basal insulin
por: Zisman, Ariel, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_c6p8t7tb6p7r6ac0edn1eig8hg